世界の組換えベクターワクチン市場：専門的調査

• 英文タイトル：Global Recombinant Vector Vaccines Market Professional Survey Report 2019

• レポートコード：QYR9ST13346
• 出版社/出版日：QYResearch / 2019年9月10日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、117ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥518,000 (USD3,500)	▷ お問い合わせ
Enterprise License	￥1,036,000 (USD7,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートは、組換えベクターワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他に、用途別には、大人用、子供用にセグメント区分し、組換えベクターワクチンの世界市場を分析しました。

・エグゼクティブ・サマリー
・組換えベクターワクチンの世界市場概要
・組換えベクターワクチンの製造コスト構成分析
・組換えベクターワクチンの開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・組換えベクターワクチンの地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・組換えベクターワクチンのセグメント分析（種類別）
（水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他）
・組換えベクターワクチンのセグメント分析（用途別）
（大人用、子供用）
・組換えベクターワクチンの主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（SANOFI PASTEUR S.A.、Novartis、GSK、CNBG、ChengDa Bio、Changsheng Life、Zhifei、SINOVAC BIOTECH、NuoCheng Bio、Hualan Bio、Kangtai）
・組換えベクターワクチンの市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

Recombinant vector vaccines are experimental vaccines similar to DNA vaccines, but they use an attenuated virus or bacterium to introduce microbial DNA to cells of the body. “Vector” refers to the virus or bacterium used as the carrier.In nature, viruses latch on to cells and inject their genetic material into them. In the lab, scientists have taken advantage of this process. They have figured out how to take the roomy genomes of certain harmless or attenuated viruses and insert portions of the genetic material from other microbes into them. The carrier viruses then ferry that microbial DNA to cells. Recombinant vector vaccines closely mimic a natural infection and therefore do a good job of stimulating the immune system.
Attenuated bacteria also can be used as vectors. In this case, the inserted genetic material causes the bacteria to display the antigens of other microbes on its surface. In effect, the harmless bacterium mimics a harmful microbe, provoking an immune response.
Researchers are working on both bacteria-l and viral-based recombinant vector vaccines for HIV, rabies, and measles.

The global Recombinant Vector Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Recombinant Vector Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Vector Vaccines market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Vector Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Recombinant Vector Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
SANOFI PASTEUR S.A.
Novartis
GSK
CNBG
ChengDa Bio
Changsheng Life
Zhifei
SINOVAC BIOTECH
NuoCheng Bio
Hualan Bio
Kangtai

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Others

Segment by Application
For Adult
For Child

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Recombinant Vector Vaccines
1.1 Definition of Recombinant Vector Vaccines
1.2 Recombinant Vector Vaccines Segment by Type
1.2.1 Global Recombinant Vector Vaccines Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, tetanus
1.2.10 Pneumococcal
1.2.11 Others
1.3 Recombinant Vector Vaccines Segment by Applications
1.3.1 Global Recombinant Vector Vaccines Consumption Comparison by Applications (2014-2025)
1.3.2 For Adult
1.3.3 For Child
1.4 Global Recombinant Vector Vaccines Overall Market
1.4.1 Global Recombinant Vector Vaccines Revenue (2014-2025)
1.4.2 Global Recombinant Vector Vaccines Production (2014-2025)
1.4.3 North America Recombinant Vector Vaccines Status and Prospect (2014-2025)
1.4.4 Europe Recombinant Vector Vaccines Status and Prospect (2014-2025)
1.4.5 China Recombinant Vector Vaccines Status and Prospect (2014-2025)
1.4.6 Japan Recombinant Vector Vaccines Status and Prospect (2014-2025)
1.4.7 Southeast Asia Recombinant Vector Vaccines Status and Prospect (2014-2025)
1.4.8 India Recombinant Vector Vaccines Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Recombinant Vector Vaccines
2.3 Manufacturing Process Analysis of Recombinant Vector Vaccines
2.4 Industry Chain Structure of Recombinant Vector Vaccines

3 Development and Manufacturing Plants Analysis of Recombinant Vector Vaccines
3.1 Capacity and Commercial Production Date
3.2 Global Recombinant Vector Vaccines Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Recombinant Vector Vaccines
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Recombinant Vector Vaccines Production and Capacity Analysis
4.2 Recombinant Vector Vaccines Revenue Analysis
4.3 Recombinant Vector Vaccines Price Analysis
4.4 Market Concentration Degree

5 Recombinant Vector Vaccines Regional Market Analysis
5.1 Recombinant Vector Vaccines Production by Regions
5.1.1 Global Recombinant Vector Vaccines Production by Regions
5.1.2 Global Recombinant Vector Vaccines Revenue by Regions
5.2 Recombinant Vector Vaccines Consumption by Regions
5.3 North America Recombinant Vector Vaccines Market Analysis
5.3.1 North America Recombinant Vector Vaccines Production
5.3.2 North America Recombinant Vector Vaccines Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Recombinant Vector Vaccines Import and Export
5.4 Europe Recombinant Vector Vaccines Market Analysis
5.4.1 Europe Recombinant Vector Vaccines Production
5.4.2 Europe Recombinant Vector Vaccines Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Recombinant Vector Vaccines Import and Export
5.5 China Recombinant Vector Vaccines Market Analysis
5.5.1 China Recombinant Vector Vaccines Production
5.5.2 China Recombinant Vector Vaccines Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Recombinant Vector Vaccines Import and Export
5.6 Japan Recombinant Vector Vaccines Market Analysis
5.6.1 Japan Recombinant Vector Vaccines Production
5.6.2 Japan Recombinant Vector Vaccines Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Recombinant Vector Vaccines Import and Export
5.7 Southeast Asia Recombinant Vector Vaccines Market Analysis
5.7.1 Southeast Asia Recombinant Vector Vaccines Production
5.7.2 Southeast Asia Recombinant Vector Vaccines Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Recombinant Vector Vaccines Import and Export
5.8 India Recombinant Vector Vaccines Market Analysis
5.8.1 India Recombinant Vector Vaccines Production
5.8.2 India Recombinant Vector Vaccines Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Recombinant Vector Vaccines Import and Export

6 Recombinant Vector Vaccines Segment Market Analysis (by Type)
6.1 Global Recombinant Vector Vaccines Production by Type
6.2 Global Recombinant Vector Vaccines Revenue by Type
6.3 Recombinant Vector Vaccines Price by Type

7 Recombinant Vector Vaccines Segment Market Analysis (by Application)
7.1 Global Recombinant Vector Vaccines Consumption by Application
7.2 Global Recombinant Vector Vaccines Consumption Market Share by Application (2014-2019)

8 Recombinant Vector Vaccines Major Manufacturers Analysis
8.1 SANOFI PASTEUR S.A.
8.1.1 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Production Sites and Area Served
8.1.2 SANOFI PASTEUR S.A. Product Introduction, Application and Specification
8.1.3 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Novartis
8.2.1 Novartis Recombinant Vector Vaccines Production Sites and Area Served
8.2.2 Novartis Product Introduction, Application and Specification
8.2.3 Novartis Recombinant Vector Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 GSK
8.3.1 GSK Recombinant Vector Vaccines Production Sites and Area Served
8.3.2 GSK Product Introduction, Application and Specification
8.3.3 GSK Recombinant Vector Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 CNBG
8.4.1 CNBG Recombinant Vector Vaccines Production Sites and Area Served
8.4.2 CNBG Product Introduction, Application and Specification
8.4.3 CNBG Recombinant Vector Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 ChengDa Bio
8.5.1 ChengDa Bio Recombinant Vector Vaccines Production Sites and Area Served
8.5.2 ChengDa Bio Product Introduction, Application and Specification
8.5.3 ChengDa Bio Recombinant Vector Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Changsheng Life
8.6.1 Changsheng Life Recombinant Vector Vaccines Production Sites and Area Served
8.6.2 Changsheng Life Product Introduction, Application and Specification
8.6.3 Changsheng Life Recombinant Vector Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Zhifei
8.7.1 Zhifei Recombinant Vector Vaccines Production Sites and Area Served
8.7.2 Zhifei Product Introduction, Application and Specification
8.7.3 Zhifei Recombinant Vector Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 SINOVAC BIOTECH
8.8.1 SINOVAC BIOTECH Recombinant Vector Vaccines Production Sites and Area Served
8.8.2 SINOVAC BIOTECH Product Introduction, Application and Specification
8.8.3 SINOVAC BIOTECH Recombinant Vector Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 NuoCheng Bio
8.9.1 NuoCheng Bio Recombinant Vector Vaccines Production Sites and Area Served
8.9.2 NuoCheng Bio Product Introduction, Application and Specification
8.9.3 NuoCheng Bio Recombinant Vector Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Hualan Bio
8.10.1 Hualan Bio Recombinant Vector Vaccines Production Sites and Area Served
8.10.2 Hualan Bio Product Introduction, Application and Specification
8.10.3 Hualan Bio Recombinant Vector Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Kangtai

9 Development Trend of Analysis of Recombinant Vector Vaccines Market
9.1 Global Recombinant Vector Vaccines Market Trend Analysis
9.1.1 Global Recombinant Vector Vaccines Market Size (Volume and Value) Forecast 2019-2025
9.2 Recombinant Vector Vaccines Regional Market Trend
9.2.1 North America Recombinant Vector Vaccines Forecast 2019-2025
9.2.2 Europe Recombinant Vector Vaccines Forecast 2019-2025
9.2.3 China Recombinant Vector Vaccines Forecast 2019-2025
9.2.4 Japan Recombinant Vector Vaccines Forecast 2019-2025
9.2.5 Southeast Asia Recombinant Vector Vaccines Forecast 2019-2025
9.2.6 India Recombinant Vector Vaccines Forecast 2019-2025
9.3 Recombinant Vector Vaccines Market Trend (Product Type)
9.4 Recombinant Vector Vaccines Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Recombinant Vector Vaccines Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Recombinant Vector Vaccines
Table Global Recombinant Vector Vaccines Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global Recombinant Vector Vaccines Production Market Share by Types in 2018
Figure Varicella Product Picture
Figure Influenza Product Picture
Figure Polio Product Picture
Figure Hepatitis A Product Picture
Figure Rabies Product Picture
Figure BCG Product Picture
Figure Hepatitis B Product Picture
Figure Pertussis, Diphtheria, tetanus Product Picture
Figure Pneumococcal Product Picture
Figure Others Product Picture
Table Global Recombinant Vector Vaccines Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global Recombinant Vector Vaccines Consumption Market Share by Applications in 2018
Figure For Adult
Figure For Child
Figure Global Recombinant Vector Vaccines Revenue (Million USD) (2014-2025)
Figure Global Recombinant Vector Vaccines Production (K Doses) (2014-2025)
Figure North America Recombinant Vector Vaccines Market Size (Million USD) (2014-2025)
Figure Europe Recombinant Vector Vaccines Market Size (Million USD) (2014-2025)
Figure China Recombinant Vector Vaccines Market Size (Million USD) (2014-2025)
Figure Japan Recombinant Vector Vaccines Market Size (Million USD) (2014-2025)
Figure Southeast Asia Recombinant Vector Vaccines Market Size (Million USD) (2014-2025)
Figure India Recombinant Vector Vaccines Market Size (Million USD) (2014-2025)
Table Recombinant Vector Vaccines Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Recombinant Vector Vaccines in 2018
Figure Manufacturing Process Analysis of Recombinant Vector Vaccines
Figure Industry Chain Structure of Recombinant Vector Vaccines
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Recombinant Vector Vaccines Manufacturing Plants Distribution
Table Recombinant Vector Vaccines Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Recombinant Vector Vaccines Capacity (K Doses) of Major Manufacturers (2014-2019)
Table Recombinant Vector Vaccines Production (K Doses) of Major Manufacturers (2014-2019)
Table Recombinant Vector Vaccines Production Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Vector Vaccines Production Share by Manufacturers in 2018
Table Recombinant Vector Vaccines Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Recombinant Vector Vaccines Revenue Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Vector Vaccines Revenue Share by Manufacturers in 2018
Table Recombinant Vector Vaccines Average Price (USD/Dose) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Recombinant Vector Vaccines Production by Regions 2014-2019 (K Doses)
Table Global Recombinant Vector Vaccines Production Market Share by Regions 2014-2019
Figure Global Recombinant Vector Vaccines Production Market Share by Regions in 2018
Table Global Recombinant Vector Vaccines Revenue by Regions 2014-2019 (Million USD)
Table Global Recombinant Vector Vaccines Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Vector Vaccines Revenue Market Share by Regions in 2018
Table Global Recombinant Vector Vaccines Consumption by Regions 2014-2019 (K Doses)
Table Global Recombinant Vector Vaccines Consumption Market Share by Regions 2014-2019
Figure North America Recombinant Vector Vaccines Production Growth Rate 2014-2019 (K Doses)
Figure North America Recombinant Vector Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table North America Recombinant Vector Vaccines Production, Consumption Import and Export (K Doses)
Figure Europe Recombinant Vector Vaccines Production Growth Rate 2014-2019 (K Doses)
Figure Europe Recombinant Vector Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Recombinant Vector Vaccines Production, Consumption Import and Export (K Doses)
Figure China Recombinant Vector Vaccines Production Growth Rate 2014-2019 (K Doses)
Figure China Recombinant Vector Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table China Recombinant Vector Vaccines Production, Consumption Import and Export (K Doses)
Figure Japan Recombinant Vector Vaccines Production Growth Rate 2014-2019 (K Doses)
Figure Japan Recombinant Vector Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Recombinant Vector Vaccines Production, Consumption Import and Export (K Doses)
Figure Southeast Asia Recombinant Vector Vaccines Production Growth Rate 2014-2019 (K Doses)
Figure Southeast Asia Recombinant Vector Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Recombinant Vector Vaccines Production, Consumption Import and Export (K Doses)
Figure India Recombinant Vector Vaccines Production Growth Rate 2014-2019 (K Doses)
Figure India Recombinant Vector Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table India Recombinant Vector Vaccines Production, Consumption Import and Export (K Doses)
Figure Global Consumption Recombinant Vector Vaccines Market Share by Application (2014-2019)
Figure Global Value (Consumption) Recombinant Vector Vaccines Market Share by Application (2014-2019)
Table SANOFI PASTEUR S.A. Recombinant Vector Vaccines Production Sites and Area Served
Table SANOFI PASTEUR S.A. Recombinant Vector Vaccines Product Introduction, Application and Specification
Table SANOFI PASTEUR S.A. Recombinant Vector Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table SANOFI PASTEUR S.A. Recombinant Vector Vaccines Production Growth Rate (2014-2019)
Table SANOFI PASTEUR S.A. Recombinant Vector Vaccines Production Market Share (2014-2019)
Figure SANOFI PASTEUR S.A. Recombinant Vector Vaccines Revenue Market Share (2014-2019)
Table SANOFI PASTEUR S.A. Recombinant Vector Vaccines Main Business and Markets Served
Table Novartis Recombinant Vector Vaccines Production Sites and Area Served
Table Novartis Recombinant Vector Vaccines Product Introduction, Application and Specification
Table Novartis Recombinant Vector Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Novartis Recombinant Vector Vaccines Production Growth Rate (2014-2019)
Table Novartis Recombinant Vector Vaccines Production Market Share (2014-2019)
Figure Novartis Recombinant Vector Vaccines Revenue Market Share (2014-2019)
Table Novartis Recombinant Vector Vaccines Main Business and Markets Served
Table GSK Recombinant Vector Vaccines Production Sites and Area Served
Table GSK Recombinant Vector Vaccines Product Introduction, Application and Specification
Table GSK Recombinant Vector Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table GSK Recombinant Vector Vaccines Production Growth Rate (2014-2019)
Table GSK Recombinant Vector Vaccines Production Market Share (2014-2019)
Figure GSK Recombinant Vector Vaccines Revenue Market Share (2014-2019)
Table GSK Recombinant Vector Vaccines Main Business and Markets Served
Table CNBG Recombinant Vector Vaccines Production Sites and Area Served
Table CNBG Recombinant Vector Vaccines Product Introduction, Application and Specification
Table CNBG Recombinant Vector Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table CNBG Recombinant Vector Vaccines Production Growth Rate (2014-2019)
Table CNBG Recombinant Vector Vaccines Production Market Share (2014-2019)
Figure CNBG Recombinant Vector Vaccines Revenue Market Share (2014-2019)
Table CNBG Recombinant Vector Vaccines Main Business and Markets Served
Table ChengDa Bio Recombinant Vector Vaccines Production Sites and Area Served
Table ChengDa Bio Recombinant Vector Vaccines Product Introduction, Application and Specification
Table ChengDa Bio Recombinant Vector Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table ChengDa Bio Recombinant Vector Vaccines Production Growth Rate (2014-2019)
Table ChengDa Bio Recombinant Vector Vaccines Production Market Share (2014-2019)
Figure ChengDa Bio Recombinant Vector Vaccines Revenue Market Share (2014-2019)
Table ChengDa Bio Recombinant Vector Vaccines Main Business and Markets Served
Table Changsheng Life Recombinant Vector Vaccines Production Sites and Area Served
Table Changsheng Life Recombinant Vector Vaccines Product Introduction, Application and Specification
Table Changsheng Life Recombinant Vector Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Changsheng Life Recombinant Vector Vaccines Production Growth Rate (2014-2019)
Table Changsheng Life Recombinant Vector Vaccines Production Market Share (2014-2019)
Figure Changsheng Life Recombinant Vector Vaccines Revenue Market Share (2014-2019)
Table Changsheng Life Recombinant Vector Vaccines Main Business and Markets Served
Table Zhifei Recombinant Vector Vaccines Production Sites and Area Served
Table Zhifei Recombinant Vector Vaccines Product Introduction, Application and Specification
Table Zhifei Recombinant Vector Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Zhifei Recombinant Vector Vaccines Production Growth Rate (2014-2019)
Table Zhifei Recombinant Vector Vaccines Production Market Share (2014-2019)
Figure Zhifei Recombinant Vector Vaccines Revenue Market Share (2014-2019)
Table Zhifei Recombinant Vector Vaccines Main Business and Markets Served
Table SINOVAC BIOTECH Recombinant Vector Vaccines Production Sites and Area Served
Table SINOVAC BIOTECH Recombinant Vector Vaccines Product Introduction, Application and Specification
Table SINOVAC BIOTECH Recombinant Vector Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table SINOVAC BIOTECH Recombinant Vector Vaccines Production Growth Rate (2014-2019)
Table SINOVAC BIOTECH Recombinant Vector Vaccines Production Market Share (2014-2019)
Figure SINOVAC BIOTECH Recombinant Vector Vaccines Revenue Market Share (2014-2019)
Table SINOVAC BIOTECH Recombinant Vector Vaccines Main Business and Markets Served
Table NuoCheng Bio Recombinant Vector Vaccines Production Sites and Area Served
Table NuoCheng Bio Recombinant Vector Vaccines Product Introduction, Application and Specification
Table NuoCheng Bio Recombinant Vector Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table NuoCheng Bio Recombinant Vector Vaccines Production Growth Rate (2014-2019)
Table NuoCheng Bio Recombinant Vector Vaccines Production Market Share (2014-2019)
Figure NuoCheng Bio Recombinant Vector Vaccines Revenue Market Share (2014-2019)
Table NuoCheng Bio Recombinant Vector Vaccines Main Business and Markets Served
Table Hualan Bio Recombinant Vector Vaccines Production Sites and Area Served
Table Hualan Bio Recombinant Vector Vaccines Product Introduction, Application and Specification
Table Hualan Bio Recombinant Vector Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Hualan Bio Recombinant Vector Vaccines Production Growth Rate (2014-2019)
Table Hualan Bio Recombinant Vector Vaccines Production Market Share (2014-2019)
Figure Hualan Bio Recombinant Vector Vaccines Revenue Market Share (2014-2019)
Table Hualan Bio Recombinant Vector Vaccines Main Business and Markets Served
Table Kangtai Recombinant Vector Vaccines Production Sites and Area Served
Figure Global Recombinant Vector Vaccines Production (K Doses) Growth Rate Forecast 2019-2025
Figure Global Recombinant Vector Vaccines Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Recombinant Vector Vaccines Sales Price (USD/Dose) Forecast 2019-2025
Figure North America Recombinant Vector Vaccines Production Growth Rate Forecast 2019-2025 (K Doses)
Figure North America Recombinant Vector Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Recombinant Vector Vaccines Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Europe Recombinant Vector Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Recombinant Vector Vaccines Production Growth Rate Forecast 2019-2025 (K Doses)
Figure China Recombinant Vector Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Recombinant Vector Vaccines Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Japan Recombinant Vector Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Recombinant Vector Vaccines Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Southeast Asia Recombinant Vector Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Recombinant Vector Vaccines Production Growth Rate Forecast 2019-2025 (K Doses)
Figure India Recombinant Vector Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Doses) of Recombinant Vector Vaccines by Type (2019-2025)
Table Global Consumption (K Doses) of Recombinant Vector Vaccines by Application (2019-2025)
Table Recombinant Vector Vaccines Distributors List
Table Recombinant Vector Vaccines Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の小児用ワクチン市場：動向・競争分析

Global Childhood Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9ST05109 2019年9月2日 117Pages
※本調査レポートでは、世界の小児用ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。小児用ワクチンの種類別には、組換えワクチン、ウイルスワクチン、多糖ワクチン、その他に、用途別には、病院、クリニックに、地域...

世界の小児用ワクチン市場：動向・競争分析

世界の組換えトリプシン溶液市場：専門的調査

Global Recombinant Trypsin Solution Market Professional Survey Report 2019
QYR9ST14213 2019年9月10日 119Pages
※本調査レポートは、組換えトリプシン溶液の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、固体、液体に、用途別には、インスリン製造、ワクチン製造、細胞培養、その...

世界のDNAワクチン市場：専門的調査

Global DNA Vaccines Market Professional Survey Report 2019
QYR9ST07548 2019年9月5日 105Pages
※本調査レポートは、DNAワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、組換えタンパク質ワクチン、遺伝子ベースのワクチンに、用途別には、人間、動物に...

伴侶動物用ワクチンの世界市場：インサイト・予測

Global Companion Animal Vaccines Market Insights, Forecast to 2025
QYR9ST02838 2019年9月2日 112Pages
※本調査レポートでは、世界の伴侶動物用ワクチン市場について調査・分析し、以下の構成でお届け致します。伴侶動物用ワクチンの種類別には、弱毒生ワクチン、共役ワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチンに、用途別には、犬、鳥、猫に、地域別には、北米、ア...

世界の犬用ワクチン市場：専門的調査

Global Dog Vaccines Market Professional Survey Report 2019
QYR9ST07553 2019年9月5日 104Pages
※本調査レポートは、犬用ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、弱毒生ワクチン、共役ワクチン、不活化ワクチン、サブユニットワクチン、トキソイド...

世界の猫用ワクチン市場：専門的調査

Global Cat Vaccines Market Professional Survey Report 2019
QYR9ST08208 2019年9月5日 107Pages
※本調査レポートは、猫用ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、弱毒生ワクチン、コンジュゲートワクチン、不活化ワクチン、サブユニットワクチン、...

獣医・動物用ワクチンの世界市場：インサイト・予測

Global Veterinary/Animal Vaccines Market Insights, Forecast to 2025
QYR9ST00280 2019年9月2日 111Pages
※本調査レポートでは、世界の獣医・動物用ワクチン市場について調査・分析し、以下の構成でお届け致します。獣医・動物用ワクチンの種類別には、生弱毒化ワクチン、不活化ワクチン、トキソイドワクチン、組換えワクチン、その他のワクチンに、用途別には、病院・診療所、その他に、地域別には、北米、アメリカ、ヨーロッパ...

組換え凝固因子の世界市場：市場規模・現状・予測

Global Recombinant Coagulation Factors Market Size, Status and Forecast 2019-2025
QYR9ST05018 2019年9月2日 93Pages
※当調査レポートでは、組換え凝固因子の世界市場について調査・分析し、組換え凝固因子の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（組換え第VIII因子、組換え第IX因子、フォンヴィレブランド因子）、...

組換え凝固因子の世界市場：市場規模・現状・予測

世界のジフテリアワクチン市場：専門的調査 Diphtheria is a bacterial infection caused by Corynebacterium diphtheriae, and it spreads through respiratory droplets and close physical contact. Diphtheria Vaccine is a vaccine produced from diphtheria toxoid (a non-toxic form of the toxin) that against Corynebacterium diphtheriae. The global Diph…
ポリオワクチンの世界市場：インサイト・予測 Polio vaccines are vaccines used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eli…
世界の小児用ワクチン市場：動向・競争分析 Childhood vaccination against diseases such as measles, meningitis and pneumonia, helps protect the developing immune systems of infants and prevents 2-3 million childhood deaths every yearIn 2018, the global Childhood Vaccines market size was xx million US$ and is forecast to xx million US in 2025,…
世界の小児用ワクチン市場：動向・競争分析 Childhood vaccination against diseases such as measles, meningitis and pneumonia, helps protect the developing immune systems of infants and prevents 2-3 million childhood deaths every yearIn 2018, the global Childhood Vaccines market size was xx million US$ and is forecast to xx million US in 2025,…
ベクトル信号発生器の世界市場：市場規模・現状・予測 Vector signal generator is a test and measurement equipment used for testing complex waveforms. This equipment was developed considering the emergence of new communication technologies and consists of a high-end radio-frequency (RF) signal generator with an IQ modulator.According to the report, the …